Pharmacotherapy of autoimmune disorders with corticosteroids and disease-modifying antirheumatic drugs (DMARDs) such as tumour necrosis factor (TNF) inhibitors can increase the susceptibility to bacterial infection, including bacterial pneumonia [14-16]. The gene discussed is TNF; the disease is bacterial pneumonia.